• The Wall Street Journal: RNA Tech Firm GreenLight Biosciences to Go Public in $1.5 Billion SPAC Deal

    25 days ago - By Green Light Biosciences

    GreenLight Biosciences goes public in a deal announced in The Wall Street Journal
    As reported by the The Wall Street Journal , GreenLight Biosciences is combining with SPAC Environmental Impact Acquistion Corp to go public in a deal that values the RNA-technology firm at about $1.5 billion. An extract from the article is below:
    “This is a company we believe will be transformative,” GreenLight Chief Executive Andrey Zarur said in an interview. “These are urgent problems that the human race is facing,” he said. The company hopes to begin clinical trials for its Covid-19 vaccine in Africa in...
    Read more ...

     

  • STAT: RNA firm GreenLight Biosciences to go public in $1.2 billion deal

    STAT: RNA firm GreenLight Biosciences to go public in $1.2 billion deal

    25 days ago - By Green Light Biosciences

    STAT covers the $1.2 billion deal that sees Greenlight Biosciences go public
    Massachusetts-based synthetic biology company, GreenLight Biosciences, whose research ranges from developing pesticide alternatives for crops to a Covid-19 vaccine candidate plans to go public to advance its RNA manufacturing platform. Read an extract from STAT's report below:
    GreenLight says its proprietary manufacturing platform allows it to make RNA more efficiently than other companies, so it is partnering with other firms while also developing its own RNA-based products. Those partners include academic...
    Read more ...

     

  • Jennifer Raymond welcomed as SVP, CMC and Manufacturing

    Jennifer Raymond welcomed as SVP, CMC and Manufacturing

    25 days ago - By Green Light Biosciences

    GreenLight Biosciences, announced the appointment of Jennifer Raymond as SVP, CMC & Manufacturing today.
    Jennifer Raymond - SVP, CMC & Manufacturing Operations
    GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, announced the appointment of Jennifer Raymond as SVP, CMC & Manufacturing today.
    Raymond joins GreenLight from GSK with more than 23 years of experience in the pharmaceutical industry, including 13 years in vaccines development, production, and Quality Assurance, across Merck, Novartis, and...
    Read more ...

     

  • GreenLight Biosciences opens RNA production facility for the next generation of agricultural products

    GreenLight Biosciences opens RNA production facility for the next generation of agricultural products

    25 days ago - By Green Light Biosciences

    GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health , today announced the opening of its manufacturing plant in Rochester, New York.
    The 17,000-square-foot facility will manufacture enzymes and RNA for a variety of agricultural applications, including the protection of honeybees.
    While the fast rollout of mRNA vaccines helped change the course of the pandemic, RNA also has numerous potential applications in plant and animal health.
    To date, however, the cost and scale of RNA production has constrained...
    Read more ...